Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

For Lilly Sales Force The Future Is Now: Reorg Emphasizes Sales Specialists

Executive Summary

Lilly is focused on increasing sales team efficiency - not reducing overall headcount - with its "sales force of the future" reorganization

You may also be interested in...



Lilly Places Additional Marketing Support Behind Cymbalta For Diabetic Pain

Lilly is ramping up initiatives behind its selective serotonin and norepinephrine reuptake inhibitor Cymbalta (duloxetine) for the diabetic pain market

Lilly Places Additional Marketing Support Behind Cymbalta For Diabetic Pain

Lilly is ramping up initiatives behind its selective serotonin and norepinephrine reuptake inhibitor Cymbalta (duloxetine) for the diabetic pain market

Video Kills The Sales Rep? Merck Rolls Out Large Scale Video Detailing

The key to successful video detailing on a large scale is effective market segmentation, Merck President-Global Human Health Peter Loescher said Dec. 12

Related Content

Topics

UsernamePublicRestriction

Register

IV001392

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel